Polyphenol stilbenes: Molecular mechanisms of defence against oxidative stress and aging-related diseases

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Reinisalo, Mika ^a   Kårlund, Anna ^a   Koskela, Ali ^a   Kaarniranta, Kai ^a,b   Karjalainen, Reijo O ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MOBILE SECURITY; NEURODEGENERATIVE DISEASES;

AGE-RELATED MACULAR DEGENERATION; ALZHEIMER'S DISEASE; MOLECULAR MECHANISM; NATURAL ANTIOXIDANTS; OVERALL EFFICIENCY; PROTECTIVE EFFECTS; STILBENE COMPOUNDS; THERAPEUTIC POTENTIALS;

OXIDATIVE STRESS;

ISORHAPONTIGENIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PHENOL DERIVATIVE; PICEATANNOL; PINOSYLVIN; PROTEIN P62; PTEROSTILBENE; RESVERATROL; RHAPONTIGENIN; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; POLYPHENOL; REACTIVE OXYGEN METABOLITE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AGE RELATED MACULAR DEGENERATION; ALZHEIMER DISEASE; ANTIOXIDANT RESPONSIVE ELEMENT; AUTOPHAGY; BLUEBERRY; CACAO; CELLULAR IMMUNITY; CRANBERRY; DRUG BIOAVAILABILITY; EUPHORBIA; GRAPE; HUMAN; HUMULUS LUPULUS; MELALEUCA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PEANUT; PINE; POLYGONUM CUSPIDATUM; REVIEW; RHEUM; SORGHUM; SPRUCE; STRAWBERRY; SUGARCANE; TOMATO; VACCINIUM MYRTILLUS; WINE; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOLOGY; SIGNAL TRANSDUCTION;

CONIFEROPHYTA; VITACEAE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DIABETES MELLITUS, TYPE 2; HUMANS; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; OBESITY; OXIDATIVE STRESS; POLYPHENOLS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STILBENES;

EID: 84934944975     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/340520     Document Type: Review

References (276)

1. L. Muller, T. Fulop, and G. Pawelec, "Immunosenescence in vertebrates and invertebrates, " Immunity & Ageing, vol. 10, no. 1, article 12, 2013
2. R. Dai, H. Ge, S. Howard, and W. Qiu, "Transcriptional expression of Stilbene synthase genes are regulated developmentally and differentially in response to powderymildewinNorton and Cabernet Sauvignon grapevine, " Plant Science, vol. 197, pp. 70-76, 2012
3. E. E. Devore, J. H. Kang, M. M. B. Breteler, and F. Grodstein, "Dietary intakes of berries and flavonoids in relation to cognitive decline, " Annals of Neurology, vol. 72, no. 1, pp. 135-143, 2012
4. K. Liu, R. Zhou, B. Wang, and M.-T. Mi, "Effect of resveratrol on glucose control and insulin sensitivity: a meta-Analysis of 11 r and omized controlled trials, "The American Journal of Clinical Nutrition, vol. 99, no. 6, pp. 1510-1519, 2014
5. M. Takikawa, S. Inoue, F. Horio, and T. Tsuda, "Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of amp-Activated protein kinase in diabetic mice, " The Journal of Nutrition, vol. 140, no. 3, pp. 527-533, 2010
6. S. Vepslinen, H. Koivisto, E. Pekkarinen et al., "Anthocyaninenriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease, " The Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 360-370, 2013
7. J. Wang, M. G. Ferruzzi, L. Ho et al., "Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment, "The Journal of Neuroscience, vol. 32, no. 15, pp. 5144-5150, 2012
8. J. Chang, A. Rim and o, M. Pallas et al., "Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease, " Neurobiology of Aging, vol. 33, no. 9, pp. 2062-2071, 2012
9. E. Jeong, H.-R. Lee, J. Pyee, and H. Park, "Pinosylvin induces cell survival, migration and anti-Adhesiveness of endothelial cells via nitric oxide production, " Phytotherapy Research, vol. 27, no. 4, pp. 610-617, 2013
10. T. Macickova, K. Drabikova, R. Nosal' et al., "In vivo effect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis, " Neuroendocrinology Letters, vol. 31, no. 2, pp. 91-95, 2010
11. K. Bauerova, A. Acquaviva, S. Ponist et al., "Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination, " Autoimmunity, vol. 48, no. 1, pp. 46-56, 2015
12. J. Chong, A. Poutaraud, and P. Hugueney, "Metabolism and roles of stilbenes in plants, " Plant Science, vol. 177, no. 3, pp. 143-155, 2009
13. C. Parage, R. Tavares, S. Rety et al., "Structural, functional, and evolutionary analysis of the unusually large stilbene synthase gene family in grapevine, " Plant Physiology, vol. 160, no. 3, pp. 1407-1419, 2012
14. C. Rivière, A. D. Pawlus, and J.-M. Merillon, "Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae, " Natural Product Reports, vol. 29, no. 11, pp. 1317-1333, 2012
15. A. R. Fontana, A. Antoniolli, and R. Bottini, "Grape pomace as a sustainable source of bioactive compounds: extraction, characterization, and biotechnological applications of phenolics, " Journal of Agricultural and Food Chemistry, vol. 61, no. 38, pp. 8987-9003, 2013
16. S. P. Pietarinen, S. M. Willfor, M. O. Ahotupa, J. E. Hemming, and B. R. Holmbom, "Knotwood and bark extracts: strong antioxidants fromwastematerials, " Journal ofWood Science, vol. 52, no. 5, pp. 436-444, 2006
17. M.-E. Garcia-Perez, M. Royer, G. Herbette, Y. Desjardins, R. Pouliot, and T. Stevanovic, "Picea mariana bark: a new source of trans-resveratrol and other bioactive polyphenols, " Food Chemistry, vol. 135, no. 3, pp. 1173-1182, 2012
18. A. M. Rim and o, Z. Pan, J. J. Polashock et al., "In planta production of the highly potent resveratrol analogue pterostilbene via stilbene synthase and O-methyltransferase co-expression, " Plant Biotechnology Journal, vol. 10, no. 3, pp. 269-283, 2012
19. P. Jeand et, B. Delaunois, A. Conreux et al., "Biosynthesis, metabolism, molecular engineering, and biological functions of stilbene phytoalexins in plants, " Biofactors, vol. 36, no. 5, pp. 331-341, 2010
20. R. Preisig-Muller, A. Schwekendiek, I. Brehm, H.-J. Reif, and H. Kindl, "Characterization of a pine multigene family containing elicitor-responsive stilbene synthase genes, " Plant Molecular Biology, vol. 39, no. 2, pp. 221-229, 1999
21. W. J. Hurst, J.A. Glinski, K.B. Miller, J. Apgar, M. H. Davey, and D. A. Stuart, "Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products, " Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8374-8378, 2008
22. R. Flamini, M. de Rosso, F. de Marchi et al., "An innovative approach to grape metabolomics: stilbene profiling by suspect screening analysis, " Metabolomics, vol. 9, no. 6, pp. 1243-1253, 2013
23. V. Jerkovic, D. Callemien, and S. Collin, "Determination of stilbenes in hop pellets from different cultivars, " Journal of Agricultural and Food Chemistry, vol. 53, no. 10, pp. 4202-4206, 2005
24. O. Tokusoglu, M. K. Unal, and F. Yemis "Determination of the phytoalexin resveratrol (3, 5, 4-Trihydroxystilbene) in peanuts and pistachios by High-Performance Liquid Chromatographic Diode Array (HPLC-DAD) and Gas Chromatography-Mass Spectrometry (GC-MS), " Journal of Agricultural and Food Chemistry, vol. 53, no. 12, pp. 5003-5009, 2005
25. H. Latva-Maenpaa, T. Laakso, T. Sarjala, K. Wahala, and P. Saranpaa, "Variation of stilbene glucosides in bark extracts obtained from roots and stumps of Norway spruce (Picea abies L. Karst.), " Trees: Structure and Function, vol. 27, no. 1, pp. 131-139, 2013
26. N. Krafczyk, M. Kotke, N. Lehnert, and M. A. Glomb, "Phenolic composition of rhubarb, " European Food Research and Technology, vol. 228, no. 2, pp. 187-196, 2008
27. S. Y. Wang, C.-T. Chen, C. Y. Wang, and P. Chen, "Resveratrol content in strawberry fruit is affected by preharvest conditions, " Journal of Agricultural and Food Chemistry, vol. 55, no. 20, pp. 8269-8274, 2007
28. S. M. Boue, B. Y. Shih, M. E. Burow et al., "Postharvest accumulation of resveratrol and piceatannol in sugarcane with enhanced antioxidant activity, " Journal of Agricultural and Food Chemistry, vol. 61, no. 35, pp. 8412-8419, 2013
29. A. S. Ragab, J. van Fleet, B. Jankowski, J.-H. Park, and S. C. Bobzin, "Detection and quantitation of resveratrol in tomato fruit (Lycopersicon esculentum Mill.), " Journal of Agricultural and Food Chemistry, vol. 54, no. 19, pp. 7175-7179, 2006
30. A.M. Rim and o, W. Kalt, J. B. Magee, J. Dewey, and J.R. Ballington, "Resveratrol, pterostilbene, and piceatannol in Vaccinium berries, " Journal of Agricultural and Food Chemistry, vol. 52, no. 15, pp. 4713-4719, 2004
31. P. Rodriouez-Bonilla, J. M. Lopez-Nicolas, L. Mendez-Cazorla, and F. Garcia-Carmona, "Development of a reversed phase high performance liquid chromatography method based on the use of cyclodextrins as mobile phase additives to determine pterostilbene in blueberries, " Journal of Chromatography B, vol. 879, no. 15-16, pp. 1091-1097, 2011
32. R. Moss, Q. Mao, D. Taylor, and C. Saucier, "Investigation of monomeric and oligomeric wine stilbenoids in red wines by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry, " Rapid Communications in Mass Spectrometry, vol. 27, no. 16, pp. 1815-1827, 2013
33. N. Landrault, F. Larronde, J.-C. Delaunay et al., "Levels of stilbene oligomers and astilbin in French varietal wines and in grapes during noble rot development, " Journal of Agricultural and Food Chemistry, vol. 50, no. 7, pp. 2046-2052, 2002
34. S. Dore, "Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity, " NeuroSignals, vol. 14, no. 1-2, pp. 61-70, 2005
35. T. Walle, "Bioavailability of resveratrol, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 9-15, 2011
36. Y.-Y. Zhao, Q. Su, X.-L. Cheng, X.-J. Tan, X. Bai, and R.-C. Lin, "Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLCDAD-MSn, " Bioanalysis, vol. 4, no. 6, pp. 713-723, 2012
37. I. M. Kapetanovic, M. Muzzio, Z. Huang, T. N. Thompson, and D. L. McCormick, "Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats, " Cancer Chemotherapy and Pharmacology, vol. 68, no. 3, pp. 593-601, 2011
38. H.-S. Lin, B.-D. Yue, and P. C. Ho, "Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study, " Biomedical Chromatography, vol. 23, no. 12, pp. 1308-1315, 2009
39. D. J. Boocock, K. R. Patel, G. E. S. Faust et al., "Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 848, no. 2, pp. 182-187, 2007
40. V. A. Brown, K. R. Patel, M. Viskaduraki et al., "Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis, " Cancer Research, vol. 70, no. 22, pp. 9003-9011, 2010
41. K. R. Patel, V. A. Brown, D. J. L. Jones et al., "Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients, " Cancer Research, vol. 70, no. 19, pp. 7392-7399, 2010
42. A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau, "Administration of resveratrol: what formulation solutions to bioavailability limitations?" Journal of Controlled Release, vol. 158, no. 2, pp. 182-193, 2012
43. T. Ogas, T. P. Kondratyuk, and J. M. Pezzuto, "Resveratrol analogs: promising chemopreventive agents, " Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 21-29, 2013
44. M. J. Amiot, B. Romier, T.-M. Anh Dao et al., "Optimization of trans-resveratrol bioavailability for human therapy, " Biochimie, vol. 95, no. 6, pp. 1233-1238, 2013
45. Y. Sun and Y. Zhao, "Enhanced pharmacokinetics and antitumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin, " Journal of Nanoscience and Nanotechnology, vol. 12, no. 10, pp. 7677-7684, 2012
46. J. J. Johnson, M. Nihal, I. A. Siddiqui et al., "Enhancing the bioavailability of resveratrol by combining it with piperine, " Molecular Nutrition & Food Research, vol. 55, no. 8, pp. 1169-1176, 2011
47. R. L. Frozza, A. Bernardi, J. B. Hoppe et al., "Neuroprotective effects of resveratrol against A administration in rats are improved by lipid-core nanocapsules, " Molecular Neurobiology, vol. 47, no. 3, pp. 1066-1080, 2013
48. C.-H. Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, and J.-L. Beaudeux, "Resveratrol bioavailability and toxicity in humans, " Molecular Nutrition & Food Research, vol. 54, no. 1, pp. 7-16, 2010
49. L. Almeida, M. Vaz-da-Silva, A. Falcao et al., "Pharmacokinetic and safety profile of trans-resveratrol in a rising multipledose study in healthy volunteers, " Molecular Nutrition & Food Research, vol. 53, no. 1, pp. S7-S15, 2009
50. C. La Porte, N. Voduc, G. Zhang et al., "Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000mg twice daily with food, quercetin and alcohol (Ethanol) in healthy human subjects, " Clinical Pharmacokinetics, vol. 49, no. 7, pp. 449-454, 2010
51. M. Ohtsuji, F. Katsuoka, A. Kobayashi, H. Aburatani, J. D. Hayes, and M. Yamamoto, "Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes, " Journal of Biological Chemistry, vol. 283, no. 48, pp. 33554-33562, 2008
52. Y. Hirotsu, F. Katsuoka, R. Funayama et al., "Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks, " Nucleic Acids Research, vol. 40, no. 20, pp. 10228-10239, 2012
53. M. Biswas and J. Y. Chan, "Role of Nrf1 in antioxidant response element-mediated gene expression and beyond, " Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 16-20, 2010
54. N. Wakabayashi, K. Itoh, J. Wakabayashi et al., "Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation, " Nature Genetics, vol. 35, no. 3, pp. 238-245, 2003
55. M. Kobayashi and M. Yamamoto, "Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species, " Advances in Enzyme Regulation, vol. 46, no. 1, pp. 113-140, 2006
56. T. Nguyen, P. Nioi, and C. B. Pickett, "The Nrf2-Antioxidant response element signaling pathway and its activation by oxidative stress, " The Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291-13295, 2009
57. M. Zhang, C. An, Y. Gao, R. K. Leak, J. Chen, and F. Zhang, "Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection, " Progress in Neurobiology, vol. 100, no. 1, pp. 30-47, 2013
58. R. Gozzelino, V. Jeney, and M. P. Soares, "Mechanisms of cell protection by heme oxygenase-1, " Annual Review of Pharmacology and Toxicology, vol. 50, pp. 323-354, 2010
59. A. T. Dinkova-Kostova and P. Talalay, "NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector, " Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 116-123, 2010
60. E. Kansanen, H.-K. Jyrkkanen, and A.-L. Levonen, "Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids, " Free Radical Biology and Medicine, vol. 52, no. 6, pp. 973-982, 2012
61. S. B. Cullinan, J. D. Gordan, J. Jin, J.W. Harper, and J.A. Diehl, "The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase, "Molecular and Cellular Biology, vol. 24, no. 19, pp. 8477-8486, 2004
62. E. Kansanen, S. M. Kuosmanen, H. Leinonen, and A.-L. Levonenn, "The Keap1-Nrf2 pathway:mechanisms of activation and dysregulation in cancer, " Redox Biology, vol. 1, no. 1, pp. 45-49, 2013
63. J. F. Reichard, G. T. Motz, and A. Puga, "Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1, " Nucleic Acids Research, vol. 35, no. 21, pp. 7074-7086, 2007
64. Z. Sun, T. Wu, F. Zhao, A. Lau, C.M. Birch, and D. D. Zhang, "KPNA6 (Importin 7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response, " Molecular and Cellular Biology, vol. 31, no. 9, pp. 1800-1811, 2011
65. M.-K. Kwak, K. Itoh, M. Yamamoto, and T. W. Kensler, "Enhanced expression of the transcription factorNrf2 by cancer chemopreventive agents: role of antioxidant response elementlike sequences in the nrf2 promoter, " Molecular and Cellular Biology, vol. 22, no. 9, pp. 2883-2892, 2002
66. A. Jain, T. Lamark, E. Sjtem et al., "p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription, "The Journal of Biological Chemistry, vol. 285, no. 29, pp. 22576-22591, 2010
67. Y. Kawai, L. Garduño, M. Theodore, J. Yang, and I. J. Arinze, "Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization, " The Journal of Biological Chemistry, vol. 286, no. 9, pp. 7629-7640, 2011
68. A. Kokot, D. Metze, N. Mouchet et al., "Alpha-melanocytestimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin, " Endocrinology, vol. 150, no. 7, pp. 3197-3206, 2009
69. N. Wakabayashi, S. Shin, S. L. Slocum et al., "Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration, " Science Signaling, vol. 3, no. 130, p. ra52, 2010
70. W. O. Osburn, M. S. Yates, P. D. Dolan et al., "Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice, " Toxicological Sciences, vol. 104, no. 1, pp. 218-227, 2008
71. Z. Zhao, Y. Chen, J. Wang et al., "Age-related retinopathy in NRF2-deficient mice, " PLoS ONE, vol. 6, no. 4, Article ID e19456, 2011
72. B. N. Chorley, M. R. Campbell, X. Wang et al., "Identification of novel NRF2-regulated genes by ChiP-Seq: influence on retinoid X receptor alpha, " Nucleic Acids Research, vol. 40, no. 15, pp. 7416-7429, 2012
73. J. M. Marzec, J. D. Christie, S. P. Reddy et al., "Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury, " FASEB Journal, vol. 21, no. 9, pp. 2237-2246, 2007
74. S. Shin, N. Wakabayashi, V. Misra et al., "NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis, " Molecular and Cellular Biology, vol. 27, no. 20, pp. 7188-7197, 2007
75. K. L. Cheung, S. Yu, Z. Pan, J. Ma, T. Y. Wu, and A.-N. T. Kong, "TBHQ-induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1, " Chemical Research in Toxicology, vol. 24, no. 5, pp. 670-676, 2011
76. T. Nishinaka, Y. Ichijo, M. Ito et al., "Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element, " Toxicology Letters, vol. 170, no. 3, pp. 238-247, 2007
77. P. Nioi, M. McMahon, K. Itoh, M. Yamamoto, and J. D. Hayes, "Identification of a novel NRF2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence, " The Biochemical Journal, vol. 374, no. 2, pp. 337-348, 2003
78. P. Nioi and J. D. Hayes, "Contribution of NAD(P)H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors, " Mutation Research-Fundamental and MolecularMechanisms ofMutagenesis, vol. 555, no. 1-2, pp. 149-171, 2004
79. T.-C. Hsieh, X. Lu, Z. Wang, and J. M. Wu, "Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2, " Medicinal Chemistry, vol. 2, no. 3, pp. 275-285, 2006
80. Q. Cheng, J. L. Kalabus, J. Zhang, and J. G. Blanco, "A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switchNrf2, " Biochemical Pharmacology, vol. 83, no. 1, pp. 139-148, 2012
81. S. Kalthoff, U. Ehmer, N. Freiberg, M. P. Manns, and C. P. Strassburg, "Interaction between oxidative stress sensor Nrf2 and xenobiotic-Activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDPglucuronosyltransferase 1A10, "The Journal of Biological Chemistry, vol. 285, no. 9, pp. 5993-6002, 2010
82. A. C. Wild, H. R. Moinova, and R. T. Mulcahy, "Regulation of-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2, " The Journal of Biological Chemistry, vol. 274, no. 47, pp. 33627-33636, 1999
83. J.-Y. Im, K.-W. Lee, J.-M. Woo, E. Junn, and M. M. Mouradian, "Dj-1 induces thioredoxin 1 expression through the Nrf2 pathway, " Human Molecular Genetics, vol. 21, no. 13, pp. 3013-3024, 2012
84. X. Lin, H. Yang, H. Zhang, L. Zhou, and Z. Guo, "A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1), " The Journal of Biological Chemistry, vol. 288, no. 21, pp. 14815-14823, 2013
85. M. R. Campbell, M. Karaca, K. N. Adamski, B. N. Chorley, X. Wang, and D. A. Bell, "Novel hematopoietic target genes in the NRF2-Mediated transcriptional pathway, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 120305, 12 pages, 2013
86. C. J. Wruck, K. Streetz, G. Pavic et al., "Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter, "TheJournal of Biological Chemistry, vol. 286, no. 6, pp. 4493-4499, 2011
87. S. K. Niture and A. K. Jaiswal, "Nrf2 protein up-regulates antiapoptotic protein bcl-2 and prevents cellular apoptosis, " The Journal of Biological Chemistry, vol. 287, no. 13, pp. 9873-9886, 2012
88. M. Komatsu, S. Kageyama, and Y. Ichimura, "P62/SQSTM1/ A170: physiology and pathology, " Pharmacological Research, vol. 66, no. 6, pp. 457-462, 2012
89. A. M. Cuervo, L. Stafanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer, "Impaired degradation of mutant-synuclein by chaperone-mediated autophagy, " Science, vol. 305, no. 5688, pp. 1292-1295, 2004
90. J. Viiri, M. Amadio, N. Marchesi et al., "Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells, " PLoS ONE, vol. 8, no. 7, Article ID e69563, 2013
91. A. Salminen, K. Kaarniranta, A. Kauppinen et al., "Impaired autophagy and APP processing in Alzheimer's disease: the potential role of Beclin 1 interactome, " Progress in Neurobiology, vol. 106-107, pp. 33-54, 2013
92. R. Layfield, J. R. Cavey, D. Najat et al., "p62mutations, ubiquitin recognition and Paget's disease of bone, " Biochemical Society Transactions, vol. 34, no. 5, pp. 735-737, 2006
93. J.-H. Lee, W. H. Yu, A. Kumar et al., "Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimerrelated PS1 mutations, " Cell, vol. 141, no. 7, pp. 1146-1158, 2010
94. J. Moscat, M. T. Diaz-Meco, and M. W. Wooten, "Signal integration and diversification through the p62 scaffold protein, " Trends in Biochemical Sciences, vol. 32, no. 2, pp. 95-100, 2007
95. M. Komatsu, S. Waguri, M. Koike et al., "Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice, " Cell, vol. 131, no. 6, pp. 1149-1163, 2007
96. A. Lau, X.-J. Wang, F. Zhao et al., "A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between keap1 and p62, "Molecular and Cellular Biology, vol. 30, no. 13, pp. 3275-3285, 2010
97. K. Taguchi, N. Fujikawa, M. Komatsu et al., "Keap1 degradation by autophagy for the maintenance of redox homeostasis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 34, pp. 13561-13566, 2012
98. E. Itakura and N. Mizushima, "p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding, " Journal of Cell Biology, vol. 192, no. 1, pp. 17-27, 2011
99. Y. Ichimura and M. Komatsu, "Selective degradation of p62 by autophagy, " Seminars in Immunopathology, vol. 32, no. 4, pp. 431-436, 2010
100. J. M. T. Hyttinen, G. Petrovski, A. Salminen, and K. Kaarniranta, "5-Adenosine monophosphate-Activated protein kinasemammalian target of rapamycin axis as therapeutic target for age-related macular degeneration, " Rejuvenation Research, vol. 14, no. 6, pp. 651-660, 2011
101. J. Kim, M. Kundu, B. Viollet, and K.-L. Guan, "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, " Nature Cell Biology, vol. 13, no. 2, pp. 132-141, 2011
102. C. Canto, Z. Gerhart-Hines, J. N. Feige et al., "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity, " Nature, vol. 458, no. 7241, pp. 1056-1060, 2009
103. A. Gorm and , E. Henriksson, K. Strom, T. E. Jensen, K. Sakamoto, and O. Goransson, "Regulation of AMP-Activated protein kinase by LKB1 and CaMKK in adipocytes, " The Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1364-1375, 2011
104. X.-M. Liu, K. J. Peyton, A. R. Shebib, H. Wang, R. J. Korthuis, and W. Durante, "Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 1, pp. H84-H93, 2011
105. S.-J. Park, F. Ahmad, A. Philp et al., "Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases, " Cell, vol. 148, no. 3, pp. 421-433, 2012
106. M. Frombaum, S. Le Clanche, D. Bonnefont-Rousselot, and D. Borderie, "Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: potential benefits to cardiovascular diseases, " Biochimie, vol. 94, no. 2, pp. 269-276, 2012
107. F. X. Guix, I. Uribesalgo, M. Coma, and F. J. Muñoz, "The physiology and pathophysiology of nitric oxide in the brain, " Progress in Neurobiology, vol. 76, no. 2, pp. 126-152, 2005
108. M. J. Crabtree and K. M. Channon, "Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease, " Nitric Oxide: Biology and Chemistry, vol. 25, no. 2, pp. 81-88, 2011
109. J. Vasquez-Vivar, N. Hogg, P. Martasek, H. Karoui, K. A. Pritchard Jr., and B. Kalyanaraman, "Tetrahydrobiopterindependent inhibition of superoxide generation from neuronal nitric oxide synthase, " The Journal of Biological Chemistry, vol. 274, no. 38, pp. 26736-26742, 1999
110. R. H. Foxton, J. M. L and , and S. J. R. Heales, "Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms, " Neurochemical Research, vol. 32, no. 4-5, pp. 751-756, 2007
111. K. U. Schallreuter, J. Moore, D. J. Tobin et al., "-MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesis, " Annals of the New York Academy of Sciences, vol. 885, pp. 329-341, 1999
112. L. Wang, H. Erl and sen, J. Haavik, P. M. Knappskog, and R. C. Stevens, "Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin, " Biochemistry, vol. 41, no. 42, pp. 12569-12574, 2002
113. H. K. Kim, S. H. Ha, and J. Han, "Potential therapeutic applications of tetrahydrobiopterin: from inherited hyperphenylalaninemia to mitochondrial diseases, " Annals of the New York Academy of Sciences, vol. 1201, pp. 177-182, 2010
114. J. Z. Nowak and J. B. Zawilska, "Melatonin and its physiological and therapeutic properties, " PharmacyWorld& Science, vol. 20, no. 1, pp. 18-27, 1998
115. P. O. Lundmark, S. R. P and i-Perumal, V. Srinivasan, D. P. Cardinali, and R. E. Rosenstein, "Melatonin in the eye: implications for glaucoma, " Experimental Eye Research, vol. 84, no. 6, pp. 1021-1030, 2007
116. N. Xia, A. Daiber, A. Habermeier et al., "Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice, " The Journal of Pharmacology and ExperimentalTherapeutics, vol. 335, no. 1, pp. 149-154, 2010
117. J. Cai, W. G. Jiang, M. B. Grant, and M. Boulton, "Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1, " The Journal of Biological Chemistry, vol. 281, no. 6, pp. 3604-3613, 2006
118. V. M. Lopez, C. L. Decatur, W. D. Stamer, R. M. Lynch, and B. S. McKay, "L-DOPA is an endogenous lig and for OA1, " PLoS Biology, vol. 6, no. 9, article e236, 2008
119. B. Omar, E. Zmuda-Trzebiatowska, V. Manganiello, O. Goransson, and E. Degerman, "Regulation of AMPactivated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis, " Cellular Signalling, vol. 21, no. 5, pp. 760-766, 2009
120. S. R. Kulkarni, A. C. Donepudi, J. Xu et al., "Fasting induces nuclear factor E2-related factor 2 and ATP-binding cassette transporters via protein kinase a and sirtuin-1 in mouse and human, " Antioxidants & Redox Signaling, vol. 20, no. 1, pp. 15-30, 2014
121. H.-W. Lo and F. Ali-Osman, "CyclicAMPmediatedGSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation, " Journal of Cellular Biochemistry, vol. 87, no. 1, pp. 103-116, 2002
122. H. Si, J. Yu, H. Jiang, H. Lum, and D. Liu, "Phytoestrogen genistein up-regulates endothelial nitric oxide synthase expression via activation of cAMP response element-binding protein in human aortic endothelial cells, " Endocrinology, vol. 153, no. 7, pp. 3190-3198, 2012
123. D. de Rasmo, A. Signorile, F. Papa, E. Roca, and S. Papa, "cAMP/Ca2+ response element-binding protein plays a central role in the biogenesis of respiratory chain proteins in mammalian cells, " IUBMB Life, vol. 62, no. 6, pp. 447-452, 2010
124. D. G. Hardie, F. A. Ross, and S. A. Hawley, "AMPK: a nutrient and energy sensor that maintains energy homeostasis, " Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 251-262, 2012
125. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha, " Cell, vol. 127, no. 6, pp. 1109-1122, 2006
126. B. J. Wilson, A.M. Tremblay, G. Deblois, G. Sylvain-Drolet, and V. Giguère, "An acetylation switchmodulates the transcriptional activity of estrogen-related receptor , " Molecular Endocrinology, vol. 24, no. 7, pp. 1349-1358, 2010
127. C. Mo, L. Wang, J. Zhang et al., "The crosstalk betweenNrf2 and AMPK signal pathways is important for the anti-inflammatory effect of Berberine in LPS-stimulated macrophages and endotoxin-shocked mice, " Antioxidants & Redox Signaling, vol. 20, no. 4, pp. 574-588, 2014
128. C.H and schin and U. A. Meyer, "Induction of drugmetabolism: the role of nuclear receptors, " Pharmacological Reviews, vol. 55, no. 4, pp. 649-673, 2003
129. J. T. Moore, J. L. Collins, and K.H. Pearce, "Thenuclear receptor superfamily and drug discovery, " ChemMedChem, vol. 1, no. 5, pp. 504-523, 2006
130. D. Kluth, A. Banning, I. Paur, R. Blomhoff, and R. Brigelius-Flohe, "Modulation of pregnane X receptor-And electrophile responsive element-mediated gene expression by dietary polyphenolic compounds, " Free Radical Biology and Medicine, vol. 42, no. 3, pp. 315-325, 2007
131. K. C. Wu, J. Y. Cui, and C. D. Klaassen, "Effect of graded nrf2 activation on phase-I and-II drug metabolizing enzymes and transporters in mouse liver, " PLoS ONE, vol. 7, no. 7, Article ID e39006, 2012
132. T. Haarmann-Stemmann, H. Bothe, and J. Abel, "Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways, " Biochemical Pharmacology, vol. 77, no. 4, pp. 508-520, 2009
133. R.L. Yeager, S. A. Reisman, L.M. Aleksunes, and C.D. Klaassen, "Introducing the 'TCDD-inducible AhR-Nrf2 gene battery', " Toxicological Sciences, vol. 111, no. 2, pp. 238-246, 2009
134. E. R. Levin, "Integration of the extranuclear and nuclear actions of estrogen, " Molecular Endocrinology, vol. 19, no. 8, pp. 1951-1959, 2005
135. A. L. Ososki and E. J. Kennelly, "Phytoestrogens: a review of the present state of research, " Phytotherapy Research, vol. 17, no. 8, pp. 845-869, 2003
136. R. Lappano, C. Rosano, A. Madeo et al., "Structure-Activity relationships of resveratrol and derivatives in breast cancer cells, " Molecular Nutrition and Food Research, vol. 53, no. 7, pp. 845-858, 2009
137. M. C. Saleh, B. J. Connell, and T. M. Saleh, "Resveratrol induced neuroprotection is mediated via both estrogen receptor subtypes, ER and ER, " Neuroscience Letters, vol. 548, pp. 217-221, 2013
138. V. Di Liberto, J. Makela, L. Korhonen et al., "Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice, " Neuropharmacology, vol. 62, no. 2, pp. 1011-1018, 2012
139. A. Tchernof and J.-P. Despres, "Pathophysiology of human visceral obesity: an update, " Physiological Reviews, vol. 93, no. 1, pp. 359-404, 2013
140. D. A. Sinclair, "Toward a unified theory of caloric restriction and longevity regulation, " Mechanisms of Ageing and Development, vol. 126, no. 9, pp. 987-1002, 2005
141. L. Fontana, L. Partridge, and V. D. Longo, "Extending healthy life span-from yeast to humans, " Science, vol. 328, no. 5976, pp. 321-326, 2010
142. A. Soare, R. Cangemi, D. Omodei, J. O. Holloszy, and L. Fontana, "Long-term calorie restriction, but not endurance exercise, lowers core body temperature in humans, " Aging, vol. 3, no. 4, pp. 374-379, 2011
143. A. V. Witte, M. Fobker, R. Gellner, S. Knecht, and A. Floel, "Caloric restriction improves memory in elderly humans, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 4, pp. 1255-1260, 2009
144. C.-L. Hsu and G.-C. Yen, "Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanism, " Molecular Nutrition & Food Research, vol. 52, no. 1, pp. 53-61, 2008
145. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: the in vivo evidence, " Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006
146. A.-S. Cheng, Y.-H. Cheng, C.-H. Chiou, and T.-L. Chang, "Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in hep G2 cells, " Journal of Agricultural and Food Chemistry, vol. 60, no. 36, pp. 9180-9187, 2012
147. E. Tauriainen, M. Luostarinen, E. Martonen et al., "Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation, " Journal of Nutrition and Metabolism, vol. 2011, Article ID 525094, 10 pages, 2011
148. T. Ito-Nagahata, C. Kurihara, M. Hasebe et al., "Stilbene analogs of resveratrol improve insulin resistance through activation of AMPK, " Bioscience, Biotechnology and Biochemistry, vol. 77, no. 6, pp. 1229-1235, 2013
149. P. Fischer-Posovszky, V. Kukulus, D. Tews et al., "Resveratrol regulates human adipocyte number and function in a Sirt1-dependentmanner, "TheAmerican Journal of Clinical Nutrition, vol. 92, no. 1, pp. 5-15, 2010
150. T. T. Schug and X. Li, "Sirtuin 1 in lipid metabolism and obesity, " Annals of Medicine, vol. 43, no. 3, pp. 198-211, 2011
151. I. Mader, M. Wabitsch, K.-M. Debatin, P. Fischer-Posovszky, and S. Fulda, "Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis, " The FASEB Journal, vol. 24, no. 6, pp. 1997-2009, 2010
152. S. Chen, X. Xiao, X. Feng et al., "Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression, " The Journal of Nutritional Biochemistry, vol. 23, no. 9, pp. 1100-1112, 2012
153. Y. S. Jeong, J. H. Hong, K. H. Cho, and H. K. Jung, "Grape skin extract reduces adipogenesis-And lipogenesis-related gene expression in 3T3-L1 adipocytes through the peroxisome proliferator-Activated receptor-signaling pathway, " Nutrition Research, vol. 32, no. 7, pp. 514-521, 2012
154. X.-H. Zhang, B. Huang, S.-K. Choi, and J.-S. Seo, "Anti-obesity effect of resveratrol-Amplified grape skin extracts on 3T3-L1 adipocytes differentiation, " Nutrition Research and Practice, vol. 6, no. 4, pp. 286-293, 2012
155. D. Y. Jung, U. Chalasani, N. Pan et al., "KLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance, " PLoS ONE, vol. 8, no. 10, Article IDe77851, 2013
156. A. Lasa, M. Schweiger, P. Kotzbeck et al., "Resveratrol regulates lipolysis via adipose triglyceride lipase, " The Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 379-384, 2012
157. P. Chakrabarti, T. English, S. Karki et al., "SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL, " Journal of Lipid Research, vol. 52, no. 9, pp. 1693-1701, 2011
158. C. D. S. Costa, F. Rohden, T. O. Hammes et al., "Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPAR1-3 mRNA expression in human visceral adipocytes, " Obesity Surgery, vol. 21, no. 3, pp. 356-361, 2011
159. T. Shan, Y. Ren, and Y. Wang, "Sirtuin 1 affects the transcriptional expression of adipose triglyceride lipase in porcine adipocytes, " Journal of Animal Science, vol. 91, no. 3, pp. 1247-1254, 2013
160. T. O. Hammes, C. D. S. Costa, F. Rohden et al., "Parallel downregulation of FOXO1, PPAR and adiponectin mRNA expression in visceral adipose tissue of class III obese individuals, " Obesity Facts, vol. 5, no. 3, pp. 452-459, 2012
161. J. H. Chung, V. Manganiello, and J. R. B. Dyck, "Resveratrol as a calorie restriction mimetic: therapeutic implications, " Trends in Cell Biology, vol. 22, no. 10, pp. 546-554, 2012
162. J. Lee, E. Jung, J. Lim et al., "Involvement of nuclear factor-B in the inhibition of pro-inflammatory mediators by pinosylvin, " Planta Medica, vol. 72, no. 9, pp. 801-806, 2006
163. M. Frombaum, P. Therond, R. Djelidi, J.-L. Beaudeux, D. Bonnefont-Rousselot, and D. Borderie, "Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress, " Free Radical Research, vol. 45, no. 3, pp. 293-302, 2011
164. A. Overman, A. Bumrungpert, A. Kennedy et al., "Polyphenolrich grape powder extract (GPE) attenuates inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media, " International Journal of Obesity, vol. 34, no. 5, pp. 800-808, 2010
165. C.-C. Chuang, A. Bumrungpert, A. Kennedy et al., "Grape powder extract attenuates tumor necrosis factor-mediated inflammation and insulin resistance in primary cultures of human adipocytes, " Journal of Nutritional Biochemistry, vol. 22, no. 1, pp. 89-94, 2011
166. J. Olholm, S. K. Paulsen, K. B. Cullberg, B. Richelsen, and S. B. Pedersen, "Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants, " International Journal of Obesity, vol. 34, no. 10, pp. 1546-1553, 2010
167. G. Alberdi, V. M. Rodriouez, J. Mir and a, M. T. Macarulla, I. Churruca, and M. P. Portillo, "Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats, " Food Chemistry, vol. 141, no. 2, pp. 1530-1535, 2013
168. H. J. Park, J.-Y. Yang, S. Ambati et al., "Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes, " Journal of Medicinal Food, vol. 11, no. 4, pp. 773-783, 2008
169. M. Herranz-Lopez, S. Fernandez-Arroyo, A. Perez-Sanchez et al., "Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications, " Phytomedicine, vol. 19, no. 3-4, pp. 253-261, 2012
170. G.-M. Do, U. J. Jung, H.-J. Park et al., "Resveratrol ameliorates diabetes-related metabolic changes via activation of AMPactivated protein kinase and its downstream targets in db/db mice, " Molecular Nutrition & Food Research, vol. 56, no. 8, pp. 1282-1291, 2012
171. W. Kang, H. J. Hong, J. Guan et al., "Resveratrol improves insulin signaling in a tissue-specific manner under insulinresistant conditions only: in vitro and in vivo experiments in rodents, " Metabolism: Clinical and Experimental, vol. 61, no. 3, pp. 424-433, 2012
172. M. Minakawa, Y. Miura, and K. Yagasaki, "Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice, " Biochemical and Biophysical Research Communications, vol. 422, no. 3, pp. 469-475, 2012
173. Z. Tan, L.-J. Zhou, P.-W. Mu et al., "Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats, " The Journal of Nutritional Biochemistry, vol. 23, no. 12, pp. 1716-1724, 2012
174. T. Matsui, T. Ueda, T. Oki, K. Sugita, N. Terahara, and K. Matsumoto, "-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity, " Journal of Agricultural and Food Chemistry, vol. 49, no. 4, pp. 1948-1951, 2001
175. A. C. L. Barbosa, M. D. S. Pinto, D. Sarkar, C. Ankolekar, D. Greene, and K. Shetty, "Varietal influences on antihyperglycemia properties of freshly harvested apples using in vitro assaymodels, " Journal ofMedicinal Food, vol. 13, no. 6, pp. 1313-1323, 2010
176. D. Grussu, D. Stewart, and G. J. McDougall, "Berry polyphenols inhibit-Amylase in vitro: identifying active components in rowanberry and raspberry, " Journal of Agricultural and Food Chemistry, vol. 59, no. 6, pp. 2324-2331, 2011
177. I. Kubo, Y. Murai, I. Soediro, S. Soetarno, and S. Sastrodihardjo, "Efficient isolation of glycosidase inhibitory stilbene glycosides fromRheumpalmatum, " Journal of Natural Products, vol. 54, no. 4, pp. 1115-1118, 1991
178. K. S. Babu, A. K. Tiwari, P. V. Srinivas, A. Z. Ali, B. C. Raju, and J. M. Rao, "Yeast and mammalian-glucosidase inhibitory constituents from Himalayan rhubarb Rheum emodi Wall. ex Meisson, " Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 14, pp. 3841-3845, 2004
179. Z. Kerem, I. Bilkis, M. A. Flaishman, and L. Sivan, "Antioxidant activity and inhibition of-glucosidase by trans-resveratrol, piceid, and a novel trans-stilbene from the roots of Israeli Rumex bucephalophorus L., " Journal of Agricultural and Food Chemistry, vol. 54, no. 4, pp. 1243-1247, 2006
180. S.-H. Lam, J.-M. Chen, C.-J. Kang, C.-H. Chen, and S.-S. Lee, "Alpha-glucosidase inhibitors from the seeds of syagrus romanzoffiana, " Phytochemistry, vol. 69, no. 5, pp. 1173-1178, 2008
181. X. Wan, X.-B. Wang, M.-H. Yang, J.-S. Wang, and L.-Y. Kong, "Dimerization of piceatannol by Momordica charantia peroxidase and-glucosidase inhibitory activity of the biotransformation products, " Bioorganic and Medicinal Chemistry, vol. 19, no. 17, pp. 5085-5092, 2011
182. M. Miao, H. Jiang, B. Jiang, T. Zhang, S. W. Cui, and Z. Jin, "Phytonutrients for controlling starch digestion: evaluation of grape skin extract, " Food Chemistry, vol. 145, pp. 205-211, 2014
183. P. Chakrabarti and K. V. K and ror, "FoxO1 controls insulindependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes, "The Journal of Biological Chemistry, vol. 284, no. 20, pp. 13296-13300, 2009
184. Y.-E. Lee, J.-W. Kim, E.-M. Lee et al., "Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice, " PLoS ONE, vol. 7, no. 11, Article ID e50412, 2012
185. J.-M. Yun, A. Chien, I. Jialal, and S. Devaraj, "Resveratrol upregulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights, " Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 699-705, 2012
186. F. Paneni, J. A. Beckman, M. A. Creager, and F. Cosentino, "Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part I, " European Heart Journal, vol. 34, no. 31, pp. 2436-2446, 2013
187. B. B. Dokken, "The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids, " Diabetes Spectrum, vol. 21, no. 3, pp. 160-165, 2008
188. N. J. Alp, S. Mussa, J. Khoo et al., "Tetrahydrobiopterindependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression, " Journal of Clinical Investigation, vol. 112, no. 5, pp. 725-735, 2003
189. H. Li, N. Xia, and U. Forstermann, "Cardiovascular effects and molecular targets of resveratrol, " Nitric Oxide-Biology and Chemistry, vol. 26, no. 2, pp. 102-110, 2012
190. A. A. E. Bertelli, L. Giovannini, D. Giannessi, M. Migliori, W. Bernini, and M. Fregoni, "Antiplatelet activity of synthetic and natural resveratrol in red wine, " International Journal of Tissue Reactions, vol. 17, no. 1, pp. 1-3, 1995
191. K. R. Patel, E. Scott, V. A. Brown, A. J. Gescher, W. P. Steward, and K. Brown, "Clinical trials of resveratrol, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 161-169, 2011
192. B. Agarwal, M. J. Campen, M. M. Channell et al., "Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium, " International Journal of Cardiology, vol. 166, no. 1, pp. 246-248, 2013
193. T. Wallerath, G. Deckert, T. Ternes et al., "Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase, " Circulation, vol. 106, no. 13, pp. 1652-1658, 2002
194. P. Gresele, P. Pignatelli, G. Guglielmini et al., "Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production, " The Journal of Nutrition, vol. 138, no. 9, pp. 1602-1608, 2008
195. G. Spanier, H. Xu, N. Xia et al., "Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4), " Journal of Physiology and Pharmacology, vol. 60, pp. 111-116, 2009
196. H. Wang, Y.-J. Yang, H.-Y. Qian, Q. Zhang, H. Xu, and J.-J. Li, "Resveratrol in cardiovascular disease: what is known from current research?" Heart Failure Reviews, vol. 17, no. 3, pp. 437-448, 2012
197. M. Jang, L. Cai, G. O. Udeani et al., "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, " Science, vol. 275, no. 5297, pp. 218-220, 1997
198. H. S. Youn, J. Y. Lee, K. A. Fitzgerald, H. A. Young, S. Akira, and D. H. Hwang, "Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex, " The Journal of Immunology, vol. 175, no. 5, pp. 3339-3346, 2005
199. L. V. Johnson, W. P. Leitner, A. J. Rivest, M. K. Staples, M. J. Radeke, and D. H. Anderson, "The Alzheimer's A-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11830-11835, 2002
200. D. Sulzer, E. Mosharov, Z. Talloczy, F. A. Zucca, J. D. Simon, and L. Zecca, "Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease, " Journal of Neurochemistry, vol. 106, no. 1, pp. 24-36, 2008
201. J. M. Isas, V. Luibl, L. V. Johnson et al., "Soluble and mature amyloid fibrils in drusen deposits, " Investigative Ophthalmology and Visual Science, vol. 51, no. 3, pp. 1304-1310, 2010
202. K. Kaarniranta, A. Salminen, A. Haapasalo, H. Soininen, and M. Hiltunen, "Age-related macular degeneration (AMD): alzheimer's disease in the eye?" Journal of Alzheimer's Disease, vol. 24, no. 4, pp. 615-631, 2011
203. R. A. Nixon and D.-S. Yang, "Autophagy failure in Alzheimer's disease-locating the primary defect, " Neurobiology of Disease, vol. 43, no. 1, pp. 38-45, 2011
204. P. Hahn, A. H. Milam, and J. L. Dunaief, "Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane, " Archives of Ophthalmology, vol. 121, no. 8, pp. 1099-1105, 2003
205. S. Oshiro, M. S. Morioka, and M. Kikuchi, "Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, " Advances in Pharmacological Sciences, vol. 2011, Article ID 378278, 8 pages, 2011
206. K.M. Gehrs, D.H. Anderson, L.V. Johnson, and G. S. Hageman, "Age-related macular degeneration-emerging pathogenetic and therapeutic concepts, " Annals ofMedicine, vol. 38, no. 7, pp. 450-471, 2006
207. J. Z. Nowak, "Age-relatedmacular degeneration (AMD): pathogenesis and therapy, " Pharmacological Reports, vol. 58, no. 3, pp. 353-363, 2006
208. M. A. Williams, D. Craig, P. Passmore, and G. Silvestri, "Retinal drusen: harbingers of age, safe havens for trouble, " Age and Ageing, vol. 38, no. 6, pp. 648-654, 2009
209. K. P. Ng, B. Gugiu, K. Renganathan et al., "Retinal pigment epithelium lipofuscin proteomics, " Molecular and Cellular Proteomics, vol. 7, no. 7, pp. 1397-1405, 2008
210. H. Xu, M. Chen, and J. V. Forrester, "Para-inflammation in the aging retina, " Progress in Retinal and Eye Research, vol. 28, no. 5, pp. 348-368, 2009
211. K. Kaarniranta, D. Sinha, J. Blasiak et al., "Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration, " Autophagy, vol. 9, no. 7, pp. 973-984, 2013
212. A. Klettner, A. Kauppinen, J. Blasiak, J. Roider, A. Salminen, and K. Kaarniranta, "Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization, "The International Journal of Biochemistry & Cell Biology, vol. 45, no. 7, pp. 1457-1497, 2013
213. S. Binder, B.V. Stanzel, I. Krebs, and C. Glittenberg, "Transplantation of the RPE in AMD, " Progress in Retinal and Eye Research, vol. 26, no. 5, pp. 516-554, 2007
214. E. Arnault, C. Barrau, C. Nanteau et al., "Phototoxic action spectrum on a retinal pigment epithelium model of agerelated macular degeneration exposed to sunlight normalized conditions, " PLoS ONE, vol. 8, no. 8, Article ID e71398, 2013
215. S. G. Jarrett and M. E. Boulton, "Consequences of oxidative stress in age-related macular degeneration, " Molecular Aspects of Medicine, vol. 33, no. 4, pp. 399-417, 2012
216. J. Kopitz, F. G. Holz, E. Kaemmerer, and F. Schutt, "Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration, " Biochimie, vol. 86, no. 11, pp. 825-831, 2004
217. J. R. Sparrow and M. Boulton, "RPE lipofuscin and its role in retinal pathobiology, " Experimental Eye Research, vol. 80, no. 5, pp. 595-606, 2005
218. Y. Wu, E. Yanase, X. Feng, M. M. Siegel, and J. R. Sparrow, "Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 16, pp. 7275-7280, 2010
219. A. Zadlo, M. B. Rozanowska, J. M. Burke, and T. J. Sarna, "Photobleaching of retinal pigment epithelium melanosomes reduces their ability to inhibit iron-induced peroxidation of lipids, " Pigment Cell Research, vol. 20, no. 1, pp. 52-60, 2007
220. S. Memoli, A. Napolitano, M. D'Ischia, A. Palumbo, and G. Prota, "Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation, " Biochimica et Biophysica Acta, vol. 1346, no. 1, pp. 61-68, 1997
221. L. Hong and J.D. Simon, "Current underst and ing of the binding sites, capacity, affinity, and biological significance of metals in melanin, "The Journal of Physical Chemistry B, vol. 111, no. 28, pp. 7938-7947, 2007
222. P. Kaczara, M. Zareba, A. Herrnreiter et al., "Melanosome-iron interactions within retinal pigment epithelium-derived cells, " Pigment Cell and Melanoma Research, vol. 25, no. 6, pp. 804-814, 2012
223. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko, "Metals, oxidative stress and neurodegenerative disorders, " Molecular and Cellular Biochemistry, vol. 345, no. 1-2, pp. 91-104, 2010
224. T. Sarna, J. M. Burke, W. Korytowski et al., "Loss of melanin fromhuman RPE with aging: possible role of melanin photooxidation, " Experimental Eye Research, vol. 76, no. 1, pp. 89-98, 2003
225. R. Klein, B. E. K. Klein, E. K. Marino et al., "Early age-related maculopathy in the cardiovascular health study, " Ophthalmology, vol. 110, no. 1, pp. 25-33, 2003
226. C. L. Thompson, G. Jun, B. E. K. Klein et al., "Genetics of pigment changes and geographic atrophy, " Investigative Ophthalmology and Visual Science, vol. 48, no. 7, pp. 3005-3013, 2007
227. S. Qin and G. A. Rodrigues, "Roles of v5, FAK and MerTK in oxidative stress inhibition of RPE cell phagocytosis, " Experimental Eye Research, vol. 94, no. 1, pp. 63-70, 2012
228. T. A. Bailey, N. Kanuga, I. A. Romero, J. Greenwood, P. J. Luthert, and M. E. Cheetham, "Oxidative stress affects the junctional integrity of retinal pigment epithelial cells, " Investigative Ophthalmology and Visual Science, vol. 45, no. 2, pp. 675-684, 2004
229. M. M. Sachdeva, M. Cano, and J. T. Handa, and a, "Nrf2 signaling is impaired in the aging RPE given an oxidative insult, " Experimental Eye Research, vol. 119, pp. 111-114, 2014
230. M. Cano, R. Thimmalappula, M. Fujihara et al., "Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and age-related macular degeneration, " Vision Research, vol. 50, no. 7, pp. 652-664, 2010
231. N. Nagai, R. K. Thimmulappa, M. Cano et al., "Nrf2 is a critical modulator of the innate immune response in amodel of uveitis, " Free Radical Biology & Medicine, vol. 47, no. 3, pp. 300-306, 2009
232. A. Koskela, M. Reinisalo, J. M. Hyttinen, K. Kaarniranta, and R. O. Karjalainen, "Pinosylvin-mediated protection against oxidative stress in human retinal pigment epithelial cells, " Molecular Vision, vol. 20, pp. 760-769, 2014
233. N. M. M. Saviranta, L. Veeroos, L. J. Granlund, V.H. Hassinen, K. Kaarniranta, and R.O. Karjalainen, "Plant flavonol quercetin and isoflavone biochanin A differentially induce protection against oxidative stress and inflammation in ARPE-19 cells, " Food Research International, vol. 44, no. 1, pp. 109-113, 2011
234. X. Zou, Z. Feng, Y. Li et al., "Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways, " The Journal of Nutritional Biochemistry, vol. 23, no. 8, pp. 994-1006, 2012
235. E.-J. Park, H. J. Park, H.-J. Chung et al., "Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases, " Journal of Nutritional Biochemistry, vol. 23, no. 8, pp. 946-952, 2012
236. S. Richer, W. Stiles, L. Ulanski, D. Carroll, and C. Podella, "Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement, " Nutrients, vol. 5, no. 6, pp. 1989-2005, 2013
237. E. Brakenhielm, R. Cao, and Y. Cao, "Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes., " The FASEB Journal, vol. 15, no. 10, pp. 1798-1800, 2001
238. B. Dugas, S. Charbonnier, M. Baarine et al., "Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol, " European Journal of Nutrition, vol. 49, no. 7, pp. 435-446, 2010
239. M. Pons and M. E. Marin-Castaño, "Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo, " PLoS ONE, vol. 6, no. 2, Article ID e16722, 2011
240. Z. Ablonczy, A. Prakasam, J. Fant, A. Fauq, C. Crosson, and K. Sambamurti, "Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gammasecretase, " The Journal of Biological Chemistry, vol. 284, no. 44, pp. 30177-30186, 2009
241. C.-M. Chan, H.-H. Chang, V.-C. Wang, C.-L. Huang, and C.-F. Hung, "Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFR, PI3K/Akt and MAPK pathways, " PLoS ONE, vol. 8, no. 2, Article ID e56819, 2013
242. X.-Q. Liu, B.-J. Wu, W. H. T. Pan et al., "Resveratrolmitigates rat retinal ischemic injury: the roles ofmatrixmetalloproteinase-9, inducible nitric oxide, and heme oxygenase-1, " Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 1, pp. 33-40, 2013
243. A. P. Vin, H. Hu, Y. Zhai et al., "Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury, " Experimental Eye Research, vol. 108, pp. 72-75, 2013
244. S. Kubota, T. Kurihara, M. Ebinuma et al., "Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation, " The American Journal of Pathology, vol. 177, no. 4, pp. 1725-1731, 2010
245. C. Li, L. Wang, K. Huang, and L. Zheng, "Endoplasmic reticulumstress in retinal vascular degeneration: protective role of resveratrol, " Investigative Ophthalmology & Visual Science, vol. 53, no. 6, pp. 3241-3249, 2012
246. S. H. Kim, J. H. Park, Y. J. Kim, and K. H. Park, "The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection, "MolecularVision, vol. 19, pp. 1667-1676, 2013
247. S. Kubota, T. Kurihara, H. Mochimar et al., "Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation, " Investigative Ophthalmology & Visual Science, vol. 50, no. 7, pp. 3512-3519, 2009
248. N. M. Kalariya, M. Shoeb, A. B. M. Reddy, R. Sawhney, and K. V. Ramana, "Piceatannol suppresses endotoxin-induced ocular inflammation in rats, " International Immunopharmacology, vol. 17, no. 2, pp. 439-446, 2013
249. F. Ishizuka, M. Shimazawa, Y. Inoue et al., "Toll-like receptor 4mediates retinal ischemia/reperfusion injury through nuclear factor-B and spleen tyrosine kinase activation, " Investigative Ophthalmology and Visual Science, vol. 54, no. 8, pp. 5807-5816, 2013
250. V. Theendakara, A. Patent, C.A. P. Libeu et al., "Neuroprotective Sirtuin ratio reversed by ApoE4, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 45, pp. 18303-18308, 2013
251. Q. Dai, A. R. Borenstein, Y. Wu, J. C. Jackson, and E. B. Larson, "Fruit and vegetable juices and alzheimer's disease: the kame project, " The American Journal of Medicine, vol. 119, no. 9, pp. 751-759, 2006
252. L. Ho, M. G. Ferruzzi, E.M. Janle et al., "Identification of braintargeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease, " The FASEB Journal, vol. 27, no. 2, pp. 769-781, 2013
253. R. E. Tanzi, R. D. Moir, and S. L. Wagner, "Clearance of Alzheimer's A peptide: the many roads to perdition, " Neuron, vol. 43, no. 5, pp. 605-608, 2004
254. J. Wang, I. Santa-Maria, L. Ho et al., "Grape derived polyphenols attenuate Tau neuropathology in a mouse model of alzheimer's disease, " Journal of Alzheimer's Disease, vol. 22, no. 2, pp. 653-661, 2010
255. E. Parrella, T. Maxim, F. Maialetti et al., "Protein restriction cycles reduce IGF-1 and phosphorylated tau, and improve behavioral performance in an Alzheimer's disease mouse model, " Aging Cell, vol. 12, no. 2, pp. 257-268, 2013
256. H. Scholtzova, R. J. Kascsak, K. A. Bates et al., "Induction of toll-like receptor 9 signaling as a method for ameliorating alzheimer's disease-related pathology, " Journal of Neuroscience, vol. 29, no. 6, pp. 1846-1854, 2009
257. S. M. Rothman and M. P. Mattson, "Activity-dependent, stressresponsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan, " Neuroscience, vol. 239, pp. 228-240, 2013
258. M. Rahvar, M. Nikseresht, S. M. Shafiee et al., "Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain, " Neurochemical Research, vol. 36, no. 5, pp. 761-765, 2011
259. F. Allam, A. T. Dao, G. Chugh et al., "Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats, " The Journal of Nutrition, vol. 143, no. 6, pp. 835-842, 2013
260. C. Rendeiro, D. Vauzour, R. J. Kean et al., "Blueberry supplementation induces spatial memory improvements and regionspecific regulation of hippocampal BDNF mRNA expression in young rats, " Psychopharmacology, vol. 223, no. 3, pp. 319-330, 2012
261. P. Marambaud, H. Zhao, and P. Davies, "Resveratrol promotes clearance of Alzheimer's disease amyloid-peptides, " The Journal of Biological Chemistry, vol. 280, no. 45, pp. 37377-37382, 2005
262. K. Pallauf and G. Rimbach, "Autophagy, polyphenols and healthy ageing, " Ageing Research Reviews, vol. 12, no. 1, pp. 237-252, 2013
263. N. Gurusamy, I. Lekli, S. Mukherjee et al., "Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway, " Cardiovascular Research, vol. 86, no. 1, pp. 103-112, 2010
264. L. Fontana, "The scientific basis of caloric restriction leading to longer life, " Current Opinion in Gastroenterology, vol. 25, no. 2, pp. 144-150, 2009
265. W. Rizza, N. Veronese, and L. Fontana, "What are the roles of calorie restriction and diet quality in promoting healthy longevity?" Ageing Research Reviews, vol. 13, no. 1, pp. 38-45, 2014
266. D. Porquet, G. Casadess, S. Bayod et al., "Dietary resveratrol prevents alzheimer'smarkers and increases life span in SAMP8, " Age, vol. 35, no. 5, pp. 1851-1865, 2013
267. S. M. de la Monte, "Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease, " Current Alzheimer Research, vol. 9, no. 1, pp. 35-66, 2012
268. B. Dasgupta and J. Milbr and t, "Resveratrol stimulates AMP kinase activity in neurons, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 17, pp. 7217-7222, 2007
269. B. T. Jeon, E. A. Jeong, H. J. Shin et al., "Resveratrol attenuates obesity-Associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet, " Diabetes, vol. 61, no. 6, pp. 1444-1454, 2012
270. Y. Jimenez-Gomez, J. A. Mattison, K. J. Pearson et al., "Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on highfat, high-sugar diet, " CellMetabolism, vol. 18, no. 4, pp. 533-545, 2013
271. S. Timmers, E. Konings, L. Bilet et al., "Calorie restrictionlike effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, " Cell Metabolism, vol. 14, no. 5, pp. 612-622, 2011
272. J. Tome-Carneiro, M. Gonzalvez, M. Larrosa et al., "Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease, " Cardiovascular Drugs and Therapy, vol. 27, no. 1, pp. 37-48, 2013
273. V. Solfrizzi, V. Frisardi, D. Seripa et al., "Mediterranean diet in predementia and dementia syndromes, " Current Alzheimer Research, vol. 8, no. 5, pp. 520-542, 2011
274. V. Solfrizzi, F. Panza, V. Frisardi et al., "Diet and alzheimer's disease risk factors or prevention: the current evidence, " Expert Review of Neurotherapeutics, vol. 11, no. 5, pp. 677-708, 2011
275. L. Ho, L. H. Chen, J. Wang et al., "Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration, " Journal of Alzheimer's Disease, vol. 16, no. 1, pp. 59-72, 2009
276. P. Scheltens, P. J. G. H. Kamphuis, F. R. J. Verhey et al., "Efficacy of a medical food in mild Alzheimer's disease: a r and omized, controlled trial, " Alzheimer's and Dementia, vol. 6, no. 1, pp. 1.e1-10.e1, 2010